Brief: Evolus Q2 Adjusted Gross Margin 71.5%
31/07/2024 21:05
Jul 31 (Reuters) - Evolus Q2 gross profit USD 47.068 million. * Q2 gross margin 70.3% * Q2 net income USD -11.35 million * outlook FY sales growth 34% * outlook FY sales USD 260-270 million
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe